Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Account Payables: 2022-2025

Historic Change in Account Payables for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $2.0 million.

  • Praxis Precision Medicines' Change in Account Payables fell 71.64% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 100.22%. This contributed to the annual value of $6.7 million for FY2024, which is 175.81% up from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Change in Account Payables is $2.0 million, which was down 66.45% from $5.9 million recorded in Q2 2025.
  • Praxis Precision Medicines' Change in Account Payables' 5-year high stood at $10.4 million during Q1 2025, with a 5-year trough of -$9.0 million in Q2 2023.
  • Moreover, its 3-year median value for Change in Account Payables was $2.0 million (2025), whereas its average is $1.5 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first slumped by 519.89% in 2023, then spiked by 883.67% in 2024.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Change in Account Payables stood at $4.5 million in 2022, then crashed by 128.55% to -$1.3 million in 2023, then slumped by 91.07% to -$2.5 million in 2024, then slumped by 71.64% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $5.9 million for Q2 2025, and $10.4 million during Q1 2025.